American International Group, Inc. – Consensus ‘buy’ rating and 5.4% Upside Potential

Broker Ratings
[shareaholic app="share_buttons" id_name="post_below_content"]

American International Group, Inc. with ticker code (AIG) have now 16 market analysts covering the stock. The analyst consensus now points to a rating of ‘buy’. The range between the high target price and low target price is between $92.00 and $70.00 with the average target price sitting at $84.44. Given that the stocks previous close was at $80.11 and the analysts are correct then we can expect a percentage increase in value of 5.4%. Also worth taking note is the 50 day moving average now sits at $76.18 and the 200 day moving average is $67.17. The company has a market capitalization of 52.42B. The stock price for the company is currently $78.99 USD

The potential market cap would be $55,256,637,038 based on the market consensus.

The company has a dividend yield of 0.89%. Other points of data to note are a P/E ratio of 11.81, revenue per share of $68.56 and a 0.82% return on assets.

American International Group, Inc. is a global insurance company. The Company provides a range of property and casualty insurance, life insurance, retirement solutions, and other financial services to customers in over 70 countries and jurisdictions. Its diverse offerings include products and services that help businesses and individuals protect their assets, manage risks and provide for retirement security. It operates through three segments: General Insurance, Life and Retirement, and Other Operations. Its General Insurance segment consists of two segments: North America and International. Its Life and Retirement segment consists of four segments: Individual Retirement, Group Retirement, Life Insurance and Institutional Markets. Its North America and International segments consist of two product categories: Commercial Lines, which consists of Liability, Financial Lines, Property and Global Specialty, and Personal Insurance, which consists of Personal Lines, and Accident and Health.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:

      Search

      Search